International Critical Care-From an Indulgence of the Best-Funded Healthcare Systems to a Core Need for the Provision of Equitable Care.

Competing Interests: Dr. Amin received funding from CIPLA LTD, Sanofi, and Pfizer. Dr. Bhagwanjee’s institution received funding from the Food and Drug Administration. Mr. Gingles received funding from Cook Medical. Dr. Jacobi received funding from La Jolla Pharmacists, Pfizer, AcelRx, and Society of Critical Care Medicine. Dr. Peden received funding from the American College of Surgeons and the Institute for Healthcare Improvement. Dr. Singer’s institution received funding from Critical Pressure, NewB, Biomerieux, Baxter, Fresenius, Biotest, Roche, and Nestle. Mr. Taylor received funding from the World Federation of Intensive and Critical Care. The remaining authors have disclosed that they do not have any potential conflicts of interest.